Delta 9 Cannabis Inc
TSX:DN

Watchlist Manager
Delta 9 Cannabis Inc Logo
Delta 9 Cannabis Inc
TSX:DN
Watchlist
Price: 0.01 CAD
Market Cap: 3.5m CAD

EV/EBIT
Enterprise Value to EBIT

-2.9
Current
-3
Median
16.8
Industry
Higher than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-2.9
=
Enterprise Value
26.8m CAD
/
EBIT
-9.4m CAD
EBIT Growth EV/EBIT to Growth
CA
Delta 9 Cannabis Inc
TSX:DN
Average EV/EBIT: 1 874.8
Negative Multiple: -2.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38.9
32%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
17.6
13%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
14.3
14%
1
CH
Roche Holding AG
SIX:ROG
10.8
6%
1.8
CH
Novartis AG
SIX:NOVN
13.1
10%
1.3
UK
AstraZeneca PLC
LSE:AZN
197
23%
8.6
US
Merck & Co Inc
NYSE:MRK
10.5
11%
1
IE
E
Endo International PLC
LSE:0Y5F
733.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.7
10%
1.1

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
N/A
2-Years Forward
EV/EBIT
N/A
3-Years Forward
EV/EBIT
N/A